Skip to contentB
Biogen Inc.
B
BIIBBiogen Inc. Q1 2018 · 10-Q
Revenue$3.13B$3.13B+11.4% vs Q1 2017 Net Income$1.17B$1.17B+56.9% vs Q1 2017 EPS Diluted$5.54$5.54+60.1% vs Q1 2017 Gross Profit$2,685,100,000+10.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biogen Inc. · CIK 875045 · Engraved from SEC EDGAR
Operating Cash Flow$1,457,100,000+519.5% Free Cash Flowderived$1,262,400,000+4,909.5% Margins · derivedGross margin85.8%−0.6 pt vs Q1 2017
Operating margin49.0%+12.6 pt vs Q1 2017
Net margin37.5%+10.9 pt vs Q1 2017
ended Mar 31, 2018 · filed Apr 24, 2018 · 24 d after period end